BioCryst Pharmaceuticals | BCRX - Eps Utile Per Azione





Eps Cambiamento Data
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Chugai Pharma JPY 87.23 16.54 2026-09
Daiichi Sankyo JPY 45.5 7.78 2026-09
DBV Technologies USD -0.7 0.15 2026-09
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Gilead Sciences USD 2.55 9.3 2026-09
GlaxoSmithKline GBP 0.55 0.04 2026-09
Glaxosmithkline GBP 0.76 0.14 2026-09
Incyte USD -3.6 6.69 2026-09
Ionis Pharmaceuticals USD 0.66 1.35 2026-09
Karyopharm Therapeutics USD -1.02 1.2 2026-03
Neurocrine Biosciences USD 3.29 0.44 2026-09
Novavax USD 0.13 0.59 2025-12
PTC Therapeutics USD -0.62 1.54 2026-09
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Roche Holding CHF 10.98 2.61 2026-06
Sarepta Therapeutics USD 0.13 0.51 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Vertex Pharmaceuticals USD 4.76 0.03 2026-09